We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
-2.83%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$192M
AUM Growth
+$3.31M
Cap. Flow
+$10.5M
Cap. Flow %
5.46%
Top 10 Hldgs %
24.46%
Holding
454
New
344
Increased
40
Reduced
39
Closed
4

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2M
2
GS icon
Goldman Sachs
GS
+$1.47M
3
GSK icon
GSK
GSK
+$1.35M
4
JNJ icon
Johnson & Johnson
JNJ
+$608K
5
TOTL icon
State Street DoubleLine Total Return Tactical ETF
TOTL
+$360K

Top Sells

Rank Stock Value
1
LNCE
Snyders-Lance, Inc.
LNCE
+$3.92M
2
BF.B icon
Brown-Forman Class B
BF.B
+$2.98M
3
WBA
Walgreens Boots Alliance
WBA
+$1.52M
4
GIS icon
General Mills
GIS
+$227K
5
YUM icon
Yum! Brands
YUM
+$225K

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.13%
2 Healthcare 17.42%
3 Financials 15.91%
4 Communication Services 8.72%
5 Industrials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PVG
351
DELISTED
PRETIUM RESOURCES INC.
PVG
$7K ﹤0.01%
+1,000
New +$7.87K
ONCE
352
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$7K ﹤0.01%
+100
New +$5.78K
AWF
353
AllianceBernstein Global High Income Fund
AWF
$876M
$6K ﹤0.01%
+500
New +$6.11K
BGS icon
354
B&G Foods
BGS
$286M
$6K ﹤0.01%
+250
New +$7.65K
BSBR icon
355
Santander
BSBR
$43.4B
$6K ﹤0.01%
+541
New +$5.67K
EBAY icon
356
eBay
EBAY
$49.4B
$6K ﹤0.01%
+150
New +$6.21K
ERNA icon
357
Eterna Therapeutics
ERNA
$4.78M
– –
0
– –
MFC icon
358
Manulife Financial
MFC
$73.9B
$6K ﹤0.01%
+344
New +$6.88K
MYGN icon
359
Myriad Genetics
MYGN
$301M
$6K ﹤0.01%
+200
New +$6.77K
NHS
360
Neuberger High Yield Strategies Fund Inc
NHS
$254M
$6K ﹤0.01%
+500
New +$5.68K
NRG icon
361
NRG Energy
NRG
$25.5B
$6K ﹤0.01%
+200
New +$5.54K
PRU icon
362
Prudential Financial
PRU
$41.7B
$6K ﹤0.01%
+57
New +$6.42K
UAA icon
363
Under Armour
UAA
$2.88B
$6K ﹤0.01%
+350
New +$5.48K
V icon
364
Visa
V
$688B
$6K ﹤0.01%
+50
New +$6.06K
WOLF icon
365
Wolfspeed
WOLF
$1.31B
$6K ﹤0.01%
+150
New +$5.65K
AMTD
366
DELISTED
TD Ameritrade Holding Corp
AMTD
$6K ﹤0.01%
+100
New +$5.67K
EVHC
367
DELISTED
Envision Healthcare Holdings Inc
EVHC
$6K ﹤0.01%
+167
New +$6.24K
AZUL
368
DELISTED
Azul
AZUL
$5K ﹤0.01%
+142
New +$4.17K
BSX icon
369
Boston Scientific
BSX
$69.2B
$5K ﹤0.01%
+200
New +$5.44K
CHTR icon
370
Charter Communications
CHTR
$18.3B
$5K ﹤0.01%
+16
New +$5.63K
ECH icon
371
iShares MSCI Chile ETF
ECH
$1.05B
$5K ﹤0.01%
+102
New +$5.52K
EPU icon
372
iShares MSCI Peru and Global Exposure ETF
EPU
$562M
$5K ﹤0.01%
+111
New +$4.69K
IUSG icon
373
iShares Core S&P US Growth ETF
IUSG
$33.5B
$5K ﹤0.01%
+100
New +$5.61K
SCSC icon
374
Scansource
SCSC
$1.17B
$5K ﹤0.01%
+150
New +$5.13K
CY
375
DELISTED
Cypress Semiconductor
CY
$5K ﹤0.01%
+300
New +$5.14K
13 14
15
16 17

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
DWA
Dorsey Wright & Associates Pasadena, California $807M AUM 65.46% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

Kavar Capital Partners Group's Q1 2018 Portfolio in Review

As of Q1 2018, Kavar Capital Partners Group held 454 positions worth $192M, up 1.8% from $188M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Kavar Capital Partners Group deployed $10.5M of net new capital in Q1 2018, opening 344 new positions and adding to 40 existing holdings. Its largest new stake was Gilead Sciences: 25,100 shares worth $1.89M.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $1.52M trimmed.

  • Kavar Capital Partners Group's largest Q1 2018 buy was Gilead Sciences: 25,100 shares worth $1.89M.
  • Kavar Capital Partners Group added most to GSK in Q1 2018, an estimated $1.35M increase.
  • Kavar Capital Partners Group's biggest Q1 2018 reduction was Walgreens Boots Alliance, cutting an estimated $1.52M.
  • Kavar Capital Partners Group fully exited Snyders-Lance, Inc. in Q1 2018, selling an estimated $3.92M.
  • Kavar Capital Partners Group's ten largest holdings make up 24% of its $192M portfolio in Q1 2018.
  • Kavar Capital Partners Group opened 344 new positions and closed 4 in Q1 2018.
  • Kavar Capital Partners Group's portfolio value rose 1.8% quarter-over-quarter to $192M.

Based on Kavar Capital Partners Group's 13F filing for Q1 2018, filed 16 May 2019.